Earnings Feed
Start Free
Home/Insiders/Balcom Alexandra
BA
SEC Insider//CIK 0001862147

Balcom Alexandra

CIK 00018621472 companiesCAMBRIDGE, MA
SEC Profile

Transactions

50

Companies

2

Filings

3

CIK

0001862147

Recent Transactions

50 trades
  • Disposition to Issuer
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-07-15−37,500→ 0 total
  • Disposition to Issuer
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-07-15−33,646→ 0 total
  • Disposition to Issuer
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-07-15−84,200→ 0 total
  • Award
    Nuvalent, Inc.$NUVL

    Class A Common Stock - Performance Stock Units

    2026-07-15+14,350→ 14,350 total
  • Disposition to Issuer
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-07-15−131,637→ 0 total
  • Disposition to Issuer
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-07-15−17,500→ 0 total
  • Disposition to Issuer
    Nuvalent, Inc.$NUVL

    Class A Common Stock - Performance Stock Units

    2026-07-15−14,350→ 0 total
  • Disposition to Issuer
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-07-15−22,933→ 0 total
  • Disposition from Tender
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-07-15$124.00/sh−44,433→ 0 total
  • Disposition to Issuer
    Nuvalent, Inc.$NUVL

    Class A Common Stock - Restricted Stock Units

    2026-07-15−41,100→ 0 total
  • Disposition to Issuer
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-07-15−8,016→ 0 total
  • Exercise/Conversion
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-07-01$18.93/sh+6,046→ 96,963 total
  • Exercise/Conversion
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-07-01−5,384→ 8,016 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-07-01$123.58/sh−11,430→ 85,533 total
  • Exercise/Conversion
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-07-01$6.89/sh+5,384→ 90,917 total
  • Exercise/Conversion
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-07-01−6,046→ 22,933 total
  • Award
    CRESCENT BIOPHARMA, INC.$CBIO

    Stock Option (Right to Buy)

    2026-06-02+11,050→ 11,050 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-06-01$100.65/sh−2,588→ 86,012 total
  • Exercise/Conversion
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-06-01−11,430→ 13,400 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-06-01$97.68/sh−900→ 92,933 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-06-01$103.84/sh−200→ 85,533 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-06-01$98.57/sh−1,200→ 91,733 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-06-01$99.86/sh−3,133→ 88,600 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-06-01$101.79/sh−279→ 85,733 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-06-01$95.99/sh−2,170→ 93,833 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-06-01$94.87/sh−960→ 96,003 total
  • Exercise/Conversion
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-06-01$6.89/sh+11,430→ 96,963 total
  • Exercise/Conversion
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-05-01−7,159→ 131,637 total
  • Exercise/Conversion
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-05-01$6.89/sh+4,271→ 96,963 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-05-01$98.42/sh−3,872→ 93,091 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-05-01$99.29/sh−7,434→ 85,657 total
  • Exercise/Conversion
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-05-01$1.08/sh+7,159→ 92,692 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-05-01$99.97/sh−124→ 85,533 total
  • Exercise/Conversion
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-05-01−4,271→ 24,830 total
  • Exercise/Conversion
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-04-01−11,430→ 138,796 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-04-01$106.18/sh−2,469→ 85,533 total
  • Exercise/Conversion
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-04-01$1.08/sh+11,430→ 96,963 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-04-01$104.39/sh−3,544→ 93,419 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-04-01$105.30/sh−5,417→ 88,002 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-03-25$100.16/sh−13,700→ 85,533 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-03-24$96.50/sh−1,160→ 99,233 total
  • Exercise/Conversion
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-03-24−11,430→ 150,226 total
  • Exercise/Conversion
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-03-24$1.08/sh+11,430→ 110,663 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-03-24$95.03/sh−2,599→ 108,064 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-03-24$95.88/sh−7,671→ 100,393 total
  • Award
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-01-07+17,500→ 99,233 total
  • Award
    Nuvalent, Inc.$NUVL

    Stock Option (Right to Buy)

    2026-01-07+17,500→ 17,500 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-01-06$97.33/sh−1,635→ 81,958 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-01-06$96.75/sh−1,321→ 83,593 total
  • Sale
    Nuvalent, Inc.$NUVL

    Class A Common Stock

    2026-01-06$98.40/sh−225→ 81,733 total

Companies

2

Recent Filings

3

Address

C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR

CAMBRIDGE, MA, 02142

View on SEC.gov